We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$122M
AUM Growth
-$1.06M
Cap. Flow
+$5.5M
Cap. Flow %
4.49%
Top 10 Hldgs %
73.33%
Holding
57
New
2
Increased
26
Reduced
3
Closed
5

Top Buys

Rank Stock Value
1
XERS icon
Xeris Biopharma Holdings
XERS
+$13.6M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$4.5M
3
RZLT icon
Rezolute
RZLT
+$4.49M
4
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$3.03M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.61M

Top Sells

Rank Stock Value
1
SBBP
Strongbridge Biopharma plc.
SBBP
+$16.4M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$3.96M
3
KALA icon
KALA BIO
KALA
+$3.19M
4
GIGGU
GigCapital4, Inc. Unit
GIGGU
+$459K
5
SWBK.U
Switchback II Corporation Units, each consisting of one Class A ordinary share and one fifth of one
SWBK.U
+$398K

Sector Composition

Rank Sector Weight
1 Healthcare 66.24%
2 Financials 10.38%
3 Communication Services 4.24%
4 Technology 3.26%
5 Consumer Discretionary 1.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDG icon
26
TransDigm Group
TDG
$73.2B
$895K 0.73%
1,407
+169
+14% +$106K
MA icon
27
Mastercard
MA
$497B
$887K 0.73%
2,469
+285
+13% +$98.6K
V icon
28
Visa
V
$697B
$863K 0.71%
3,981
+468
+13% +$100K
CRM icon
29
Salesforce
CRM
$149B
$850K 0.69%
3,346
+360
+12% +$101K
CHTR icon
30
Charter Communications
CHTR
$16.7B
$802K 0.66%
1,230
+169
+16% +$115K
DIS icon
31
Walt Disney
DIS
$172B
$787K 0.64%
5,082
+685
+16% +$111K
CVNA icon
32
Carvana
CVNA
$47.3B
$769K 0.63%
16,580
+2,150
+15% +$118K
FICO icon
33
Fair Isaac
FICO
$31B
$754K 0.62%
1,739
+254
+17% +$101K
PYPL icon
34
PayPal
PYPL
$51.4B
$685K 0.56%
3,633
+575
+19% +$124K
FLAC
35
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
$624K 0.51%
64,000
– –
BTWN
36
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$616K 0.5%
62,688
– –
SSAAU
37
DELISTED
Science Strategic Acquisition Corp. Alpha Unit
SSAAU
$613K 0.5%
62,000
– –
EIGR
38
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$607K 0.5%
3,896
-791
-17% -$153K
HMCOU
39
DELISTED
HumanCo Acquisition Corp. Unit
HMCOU
$585K 0.48%
57,724
– –
CDLX icon
40
Cardlytics
CDLX
$22.3M
$578K 0.47%
874
+194
+29% +$148K
ELEV
41
DELISTED
Elevation Oncology
ELEV
$333K 0.27%
55,299
+7,116
+15% +$49.1K
SVFA
42
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$280K 0.23%
27,900
– –
PV
43
DELISTED
Primavera Capital Acquisition Corporation
PV
$233K 0.19%
24,000
– –
SCOAU
44
DELISTED
ScION Tech Growth I Unit
SCOAU
$223K 0.18%
22,410
– –
PICC.U
45
DELISTED
Pivotal Investment Corporation III Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
PICC.U
$166K 0.14%
16,800
– –
MLTX icon
46
MoonLake Immunotherapeutics
MLTX
$1.59B
$158K 0.13%
16,009
– –
RMGCU
47
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
$109K 0.09%
11,000
– –
LUXAW
48
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
$57K 0.05%
66,666
– –
BTWNW
49
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$36K 0.03%
39,773
– –
KALA icon
50
KALA BIO
KALA
$12.3M
$16K 0.01%
5
-687
-99% -$3.19M
1
2
3

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return
KI
Khan Imran $2.93M AUM

Caxton Corporation's Q4 2021 Portfolio in Review

As of Q4 2021, Caxton Corporation held 57 positions worth $122M, down 0.86% from $123M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Caxton Corporation deployed $5.5M of net new capital in Q4 2021, opening 2 new positions and adding to 26 existing holdings. Its largest new stake was Xeris Biopharma Holdings: 6,310,546 shares worth $18.5M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 73% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Sierra Oncology, Inc. Common Stock, an estimated $3.96M trimmed.

  • Caxton Corporation's largest Q4 2021 buy was Xeris Biopharma Holdings: 6,310,546 shares worth $18.5M.
  • Caxton Corporation added most to Rezolute in Q4 2021, an estimated $4.49M increase.
  • Caxton Corporation's biggest Q4 2021 reduction was Sierra Oncology, Inc. Common Stock, cutting an estimated $3.96M.
  • Caxton Corporation fully exited Strongbridge Biopharma plc. in Q4 2021, selling an estimated $16.4M.
  • Caxton Corporation's ten largest holdings make up 73% of its $122M portfolio in Q4 2021.
  • Caxton Corporation opened 2 new positions and closed 5 in Q4 2021.
  • Caxton Corporation's portfolio value fell 0.86% quarter-over-quarter to $122M.

Based on Caxton Corporation's 13F filing for Q4 2021, filed 14 Feb 2022.